Postmarketing Surveillance Study of XGEVA (Denosumab) in South Korea (20160198)

17/04/2017
22/04/2021
EU PAS number:
EUPAS18114
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

01.20.01 Protocol Ver 1.0 2016-08-29 redacted final

English (483.34 KB - PDF) View document
Study results
Study results

Denosumab_20160198_Study_Report_Abstract_Observational_Final_Analysis_Redacted (3)

English (228.01 KB - PDF) View document
Study report
Other information